Haematuria and Modern Bladder Cancer Treatment
|
|
- Melvyn Lawson
- 5 years ago
- Views:
Transcription
1 Haematuria and Modern Bladder Cancer Treatment Mr Nikhil Vasdev MBBS MRCS MCh(Urol) FRCS(Urol) RCSEng/BAUS Robotic Fellowship Accredited and Trained Consultant Urological and Robotic Surgeon Hertfordshire and Bedfordshire Urological Cancer Centre Department of Urology Lister Hospital UK Associate Lecturer in Urology University of Cambridge Senior Clinical Lecturer in Urology University of Hertfordshire
2 Case 1 72 Year / Male Worked in construction for 40 years Past H/O Hypertension, Hypercholesterolaemia Smoker with 50 year pack history Family H/O Prostate cancer (Brother aged 60) Symptoms Blood in pee 2 weeks
3 History Taking Personal o Gender (Female, Male) o Age (Older, Younger) Main Complaint Haematuria +/- Associated Symptom Duration o Acute / Chronic History of presenting complaint o Onset- Sudden, Progressive, Transient, Persistent, Recurrent o Patter Gross versus microscopic, extra gromerular o Painful versus Painless
4 History Taking Past History o Urological Malignancy o Renal Stones o Urinary tract infections o Previous Abdominal Surgery, Pelvic Radiotherapy History of smoking Occupational History Drug History : Anticoagulation
5 Common Symptom in clinic I have had some discomfort whilst voiding but my symptoms have been on-going for 2 weeks
6 Initial Investigations Urine dipstick: Significant haematuria is 1+ or greater Trace haematuria is not significant and should be considered negative Proteinuria Transient causes must be excluded before the presence of significant haematuria can be established: Urinary tract infection (UTI): A diagnosis of UTI may be excluded if urine dipstick is negative for both leucocytes and nitrites ii urine dipstick is positive for either leucocytes or nitrites the sample must be sent for microscopy and culture negative pyuria and culture excludes UTI
7 Important Considerations Consider a prostate-specific antigen (PSA) test and a digital rectal examination to assess for prostate cancer in men with visible haematuria Consider direct access ultrasound scan to assess for endometrial cancer if vaginal bleeding cannot be excluded
8 Common Causes of Haematuria
9 What is the definition of Haematuria Joint Consensus Statement (Renal Association / British Association of Urological Surgeons) Visible Haematuria (VH). Otherwise referred to as macroscopic haematuria or gross haematuria Non-Visible Haematuria (NVH). Otherwise referred to as microscopic haematuria or dipstick positive haematuria. This is further sub-divided as follows: o Symptomatic Non-Visible Haematuria (s-nvh). Symptoms such as voiding lower urinary tract symptoms (LUTS): hesitancy, frequency, urgency, dysuria o Asymptomatic Non-Visible Haematuria (a-nvh). Incidental detection in the absence of LUTS or upper urinary tract symptoms
10 What is Significant Haematuria? Any single episode of VH Any single episode of s-nvh (in absence of UTI or other transient causes) Persistent a-nvh (in absence of UTI or other transient causes). Persistence is defined as 2 out of 3 dipsticks positive for NVH
11 What is Significant Haematuria? Transient causes that need to be excluded before establishing the presence of significant haematuria are:- o Urinary tract infection (UTI) o Haematuria in association with UTI is not uncommon o UTI is most readily excluded by a negative dipstick result for both leucocytes and nitrites o Otherwise an MSU negative for pyuria and culture are required o Exercise induced haematuria or rarely myoglobinuria (VH and NVH) o Menstruation
12 2 WW For Bladder Cancer Age 45 and over Visible Haematuria (in the absence of UTI) and / or Visible haematuria that persists or recurs after successful treatment of urinary tract infection Age 60 and over NVH and either dysuria / raised WBC on blood test Non-urgent Referral Age 60 and over Recurrent / Persistent unexplained UTI
13 In 2008 British Association of Urological Surgeons (BAUS) haematuria guidelines recommend referral to urology for all patients with visible haematuria, regardless of age
14 2 WW For Renal Cancer Unexplained visible haematuria without urinary tract infection or Visible haematuria that persists or recurs after successful treatment of urinary tract infection
15 Nephrological Referral The need for a nephrology referral in this situation depends on factors other than simply the presence of haematuria NICE guidelines recommend a recommended if there is concurrent: o Evidence of declining GFR (by >10ml/min at any stage within the previous 5 years or by >5ml/min within the last 1 year) o Stage 4 or 5 CKD (egfr <30ml/min) o Significant proteinuria (ACR 30mg/mmol or PCR 50mg/ mmol) Isolated haematuria (i.e. in the absence of significant proteinuria) with hypertension in those aged <40 o Visible haematuria coinciding with intercurrent (usually upper respiratory tract) infection
16 Focused History
17
18 Analysis of 1740 patients attending a haematuria clinic 1067 men and 673 women 161 had a positive MSU o 20% had malignancy pick up 1249 with no UTI history and negative MSU o 24% had malignancy pick up
19 Despite selection bias inherent in this analysis, it appears that the presence of UTI does not decrease the likelihood of having a urologic malignancy diagnosed Hence, there is no indication to delay prompt evaluation in patients with haematuria and a positive urine culture collected at the haematuria clinic
20 What is the incidence of diagnosing a urological malignancy when a patient has haematuria? Symptom Diagnosis of Bladder Cancer Gross Visible Haematuria 20 % Non Visible Haematuria 2 %
21 What is the incidence of diagnosing a urological malignancy when a patient has haematuria? Symptom Diagnosis of Bladder Cancer Gross Visible Haematuria 20 % Non Visible Haematuria 2 % Irritative voiding symptoms 20% of patients (Concerning symptom of Carcinoma in Situ )
22
23 Conclusion Patients with haematuria are investigated promptly. The 2 week rule has increased the cancer detection rate
24 Is it time for a Haematuria screening programme in the UK? 1992 Britton et al dipstick test in 2356 patient Bladder cancer diagnosis 5.3 % of cohort Conclusion Large number of asymptomatic men screened and increased screening cost with no benefit
25
26 Current statistics on Cancer in England Early diagnosis of cancer is a major priority for the Government in helping to improve cancer survival It has been estimated that 10,000 deaths could be avoided each year if cancer survival in England matched the best in Europe Research evidence indicates low public awareness of the signs and symptoms of cancer
27 Cancer Research UK Public Health England National Patient Awareness and Early Diagnosis initiative NHS England Blood in Pee Campaign Department of Health Target populous is patients above 50 years
28 Important points to the public If you notice blood in your pee, even if it s just the once, tell your doctor Look before you flush This campaign aims to encourage increase symptom awareness of bladder / kidney cancer and to increase early diagnosis of both conditions
29 Aim To evaluate the potential impact of increased patient awareness with the Blood in the pee campaign on Urological referrals To evaluate stage / grade changes in bladder and kidney cancer with Blood in the pee campaign
30 GP A\endances There was a 32% increase in the number of GP attendances, compared with the same period in the previous year This is equivalent to an additional 0.29 visits per practice, per week.
31 Diagnostic investigations Ultrasound scans There was considerable variability in the recorded number of diagnostic ultrasounds (ultrasound of kidney, ultrasound & Doppler scan of kidney and ultrasound of bladder), in total and from both GP and consultant referrals There were no clear changes relating to the first national campaign but the variability makes it difficult to draw firm conclusions about this
32 Diagnostic investigations Cystoscopies There was a 3% increase in the total cystoscopy activity for December 2013 to May 2014, compared to Dec 2012 to May For waiting list cystoscopy activity, there was an 8% increase over the same period
33 Urgent GP referrals for suspected cancer Following both first and second national campaigns, there were increases in the number of urgent GP referrals for suspected urological cancers For comparator referrals, there were increases of 13% and 24%
34 Diagnoses resulting from 2WW referrals The number of diagnoses resulting from a 2WW referral increased for o Bladder (8.2%), o Kidney (22%) o Urological (14%) cancers
35 Current patient data from the Blood in pee campaign Blood in pee is a key symptom in 53% of bladder cancer patients and 18% of kidney cancer patients In 2013 o 3,340 bladder and kidney cancers were diagnosed through an emergency presentation in England (majority metastatic at presentation) o Around a fifth of all cases for bladder and kidney cancers
36 Modelling of possible impact on services Following the second national campaign, the number of referrals per working day peaked in December 2014 On average, each trust saw approximately 6 extra referrals per week, during November and December 2014
37 Data summary The Blood in pee campaign has increased public awareness of this important symptom Patient awareness has led to increase Cancer specific referrals both to GP s and Hospitals
38 East and North Herts Haematuria Clinic Urine Dipstick /? Cytology egfr Ultrasound urinary tract / CT Urogram Formal Clinical History and Full examination including a DRE Flexible Cystoscopy
39 Urine Cytology Mid Morning Urine sample Sensitivity o 84% in High grade bladder cancer o 16 % in Low grade bladder cancer Overall o 10-90% Sensitivity o % Specificity
40 Newer Biomarkers Sensitivity Specificity UroVysion (FISH) % 63-95% Microsatelite analysis 58-92% % ImmunoCyt/uCyt % 63-79% NMP22 (Bladder Chek) % 55-98% BTA stat 53-91% 56-86% BTA TRAK 53-91% 28-83% Cytokeratins 12-88% 73-95% Telomerase (TRAP) 74% 79 None of these markers have been accepted for diagnosis or follow up in patients with Bladder Cancer Vasdev N et al. Haematuria. Nova Book New York 2015 EAU Guidelines 2016
41 Diagnosis Test Ultrasound
42 CT Urogram Diagnosis Test
43 Important Considerations before requesting CT Scans for Haematuria Iodinated Contrast Media Allergy o More common if history of allergy o 2-4% = mild allergic reaction (Uticaria) o <1% = severe reaction (Broncospasm, Circulatory collapse) o Death rate estimated at 1:40-100,000 Nephrotoxic o High risk Creatinine > 200 umol/: Diabetes Heart Failure Myeloma NSAID s Gadolinium Contrast o GFR < 30 = High risk of Nephrogenic Systemic Fibrosis
44 Diagnosis Test Flexible Cystoscopy (Diagnostic Examination of Bladder)
45 Causes of Blood in urine Bladder Cancer
46 East and North Herts Blue Light Cystoscopy Programme Commences December 2016
47 Blue Light Cystoscopy
48 Advantages of Blue light cystoscopy Blue light cystoscopy has a higher sensitivity than white light cystoscopy o Patient level (92 % Versus 71 %) o Biopsy level (93 % Versus 65 %) o A metaanalysis reported a reduction in tumour recurring <10% within 12 months
49 Current Radical Cystectomy techniques offered at East and North Herts NHS Trust Open Cystectomy Robotic Cystectomy Open Neobladders Robotic Ileal Conduit
50 Robotic versus Open radical cystectomy for bladder cancer- A Systematic Review of Randomised Control Trails Bhavan Rai, Jim Adshead, Nikhil Vasdev et al submi\ed to Cochrane Reviews in Urology on 8 th September 2016 Advantages of Robotic Cystectomy over open Decreased fluid loss due to evaporation Decreased blood loss Decreased pain Shorter recovery Less bowel manipulation than with extracorporeal technique Quicker return of bowel function with less hospital stay Need to use less distal ureter (potential for lower rate of strictures) Smaller incision
51 Conclusion The NICE guideline development group recognized that the recommendations would be unlikely to cover all patients with bladder or renal cancer; however as with all NICE clinical guidelines, the recommendations are for guidance only and do not replace clinical judgment Primary care practitioners will still be expected to refer a patient who does not meet the guideline criteria for suspected bladder or renal cancer if they are concerned and think it necessary
52 Contact Private Practice location / Details privatesecvasdev@icloud.com (Location Pinehill Hospital Hitchin Spire Bushey Hospital, North London)
H(a)ematuria. FX Keeley Consultant Urologist Bristol Urological Institute
H(a)ematuria FX Keeley Consultant Urologist Bristol Urological Institute From Philadelphia to Bristol, England Southmead Hospital, 1916 Southmead Hospital, 2013 Southmead Hospital, 2014 H(a)ematuria Blood
More informationUpdate on Haematuria and Bladder Cancer
Update on Haematuria and Bladder Cancer Hugh Mostafid FRCS(urol) FEBU Consultant Urologist, Royal Surrey County Hospital and Honorary Senior Lecturer, University of Surrey Guildford None Declarations Recent
More information6 UROLOGICAL CANCERS. 6.1 Key Points
6 UROLOGICAL CANCERS 6.1 Key Points Prostate Cancer Commonest cancer in males in Scotland Approximately 99% of cases occur in men aged > 50 years About 40% of cases present in men aged < 70 years when
More information9/13/2017. Highgate Private Hospital & Whittington Health NHS Trust. London Cancer Urology Guidelines for Target Referrals. Urological Cancer Groups
London Cancer Urology Guidelines for Target Referrals Mr Paul Erotocritou MBBS BSc MSc, MRCS, FRCS (Urol)Eng Highgate Private Hospital & Whittington Health NHS Trust Urological Cancer Groups 5 groups:
More informationBladder Cancer in Primary Care. Dr Penny Kehagioglou Consultant Clinical Oncologist
Bladder Cancer in Primary Care Dr Penny Kehagioglou Consultant Clinical Oncologist Objectives Patient presentation in primary care Investigating bladder cancer Management of bladder cancer Differential
More informationCase studies: LUTS. Case 1 history. Case 1 - questions. Case 1 - outcome. Case 2 - history. Case 1 learning point 14/07/2015 DR JON REES
Case 1 history Case studies: LUTS DR JON REES A 49 year old male comes to see you he has had gradual deterioration of his flow over the last few years- he saw a colleague of yours 6 weeks ago who recorded
More informationHaematuria and Bladder Cancer
Haematuria and Bladder Cancer Dr Pardeep Kumar Consultant Urological Surgeon Haematuria 3 Haematuria Macroscopic vs Microscopic Painful vs Painless Concurrent abdo pain/urinary symptoms Previous testing?
More informationLower Urinary Tract Infection (UTI) in Males
Lower Urinary Tract Infection (UTI) in Males Clinical presentation For patients in care homes see UTI in adults where IV Antibiotics in the community may be appropriate (under development) History and
More informationMODULE 5: HEMATURIA LEARNING OBJECTIVES DEFINITION. KEY WORDS: Hematuria, Cystoscopy, Urine Cytology, UTI, bladder cancer
MODULE 5: HEMATURIA KEY WORDS: Hematuria, Cystoscopy, Urine Cytology, UTI, bladder cancer LEARNING OBJECTIVES At the end of this clerkship, the learner will be able to: 1. Define microscopic hematuria.
More informationREFERRAL GUIDELINES: UROLOGY
All patients referred to specialist clinics are assigned to a priority category based on their clinical need and related psychosocial factors. The examples given are indicative only and the clinician reviewing
More information3.1 Investigations for Patients Presenting with Haematuria Table 1
3.1 Investigations for Patients Presenting with Haematuria Table 1 Patients at risk of bacterial endocarditis should be given antibiotic prophylaxis as per local guidelines. Patients with heart valve replacements
More informationBladder cancer - suspected
Background information Information resources for patients and carers Updates to this care map Bladder cancer - clinical presentation History Examination Consider differential diagnoses Clinical indications
More informationNICE guideline on Suspected cancer: recognition and referral (2015) Education package for GPs and Nurse Practitioners Case scenarios
NICE guideline on Suspected cancer: recognition and referral (2015) Education package for GPs and Nurse Practitioners Case scenarios How to use the case scenarios The case scenarios can be used in a training
More informationQUICK REFERENCE FOR HEALTHCARE PROVIDERS
KEY MESSAGES 1 SCREENING CRITERIA Screen: Patients with DM and/or hypertension at least yearly. Consider screening patients with: Age >65 years old Family history of stage 5 CKD or hereditary kidney disease
More informationSymptoms, Diagnosis and Classification
Patient Information English 2 Symptoms, Diagnosis and Classification The underlined terms are listed in the glossary. Signs and symptoms Blood in the urine is the most common symptom when a bladder tumour
More informationDiagnosis and classification
Patient Information English 2 Diagnosis and classification The underlined terms are listed in the glossary. Signs and symptoms Blood in the urine is the most common symptom when a bladder tumour is present.
More informationGuidelines for the Management of Bladder Cancer
Guidelines for the Management of Bladder Cancer Date Approved by Network Governance July 2012 Date for Review July 2015 Changes Between Version 3 and 4 Sections 5.2 and 8 updated Page 1 of 9 1. Scope of
More informationNewcastle upon Tyne, Gateshead and Northumbria Urology guidelines
Newcastle upon Tyne, Gateshead and Northumbria Urology guidelines INTRODUCTION This document is an update of the NORTH OF TYNE AND GATESHEAD GUIDELINES FOR MANAGEMENT OF COMMON UROLOGICAL CONDITIONS IN
More informationBladder Cancer Guidelines
Bladder Cancer Guidelines Agreed by Urology CSG: October 2011 Review Date: September 2013 Bladder Cancer 1. Referral Guidelines The following patients should be considered as potentially having bladder
More informationAUCKLAND REGIONAL UROLOGY GUIDELINES AND REFERRAL RECOMMENDATIONS
AUCKLAND REGIONAL UROLOGY GUIDELINES AND REFERRAL RECOMMENDATIONS This document outlines the urological conditions currently funded at Auckland District Health Board (ADHB), Counties Manukau District Health
More informationThe innovative aspect is that it detects bladder cancer based on the novel biomarker, minichromosome maintenance complex component 5 (MCM5).
pat hways ADXBLADDER for detecting bladder cancer Medtech innovation briefing Published: 12 April 2019 nice.org.uk/guidance/mib180 Summary The technology described in this briefing is ADXBLADDER. It is
More informationGuidelines for the Management of Bladder Cancer West Midlands Expert Advisory Group for Urological Cancer
Guidelines for the Management of Bladder Cancer West Midlands Expert Advisory Group for Urological Cancer West Midlands Clinical Networks and Clinical Senate Coversheet for Network Expert Advisory Group
More informationAn Undergraduate Syllabus for Urology. Produced on behalf of the British Association of Urological Surgeons. March 2012
An Undergraduate Syllabus for Urology Produced on behalf of the British Association of Urological Surgeons March 2012 Authors H Hashim, P Jones, KJ O Flynn, I Pearce, J Royle, M Shaw, AM Sinclair Correspondence
More informationOne Stop Prostate Biopsy Protocol Author Consultation Date Approved
One Stop Prostate Biopsy Protocol Author Consultation Date Approved Urology Nurse Practioner PROTOCOL FOR MEN ATTENDING A ONE STOP PROSTATE BIOPSY CLINIC RATIONALE Prostate cancer is the most common cancer
More informationCase studies. Stephen Mark Rob Walker
Case studies Stephen Mark Rob Walker Case 1 31 yr old woman with 3 rd UTI. E coli Frequency and dysuria Asymptomatic after treatment Recurrent UTI Lower tract symptoms Coliforms Asymptomatic after treatment
More informationThey are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:
bring together everything NICE says on a topic in an interactive flowchart. are interactive and designed to be used online. They are updated regularly as new NICE guidance is published. To view the latest
More informationNORTHERN IRELAND GUIDELINES FOR MANAGEMENT OF CHRONIC KIDNEY DISEASE
NORTHERN IRELAND GUIDELINES FOR MANAGEMENT OF CHRONIC KIDNEY DISEASE Practical points for use of estimated GFR + quality outcome framework indicators Developed by GAIN and the Northern Ireland Nephrology
More informationThe diagnostic value of abdominal ultrasound, urine cytology and prostate-specific antigen testing in the lower urinary tract symptoms clinic
ORIGINAL PAPER The diagnostic value of abdominal ultrasound, urine cytology and prostate-specific antigen testing in the lower urinary tract symptoms clinic N. S. Patel, 1 C. Blick, 1 P. V. S. Kumar, 2
More informationACUTE KIDNEY INJURY A PRIMER FOR PRIMARY CARE PHYSICIANS. Myriam Farah, MD, FRCPC
ACUTE KIDNEY INJURY A PRIMER FOR PRIMARY CARE PHYSICIANS Myriam Farah, MD, FRCPC Clinical Assistant Professor Division of Nephrology, University of British Columbia November 2016 1. How to recognize acute
More informationNORTH OF TYNE AND GATESHEAD GUIDELINES FOR MANAGEMENT OF COMMON UROLOGICAL CONDITIONS IN ADULTS 18 YEARS IN PRIMARY CARE
NORTH OF TYNE AND GATESHEAD GUIDELINES FOR MANAGEMENT OF COMMON UROLOGICAL CONDITIONS IN ADULTS 18 YEARS IN PRIMARY CARE July 2013 (minor update page 11, March 2014) This document has been prepared and
More informationChildren s Services Medical Guideline
See also: NICE Guidelines These local guidelines are in conjunction with NICE UTI Algorithms Renal scarring and subsequent nephropathy are important causes of later hypertension and renal failure. Early
More informationLower Urinary Tract Symptoms (LUTS) and Nurse-Led Clinics. Sean Diver Urology Advanced Nurse Practitioner candidate Letterkenny University Hospital
Lower Urinary Tract Symptoms (LUTS) and Nurse-Led Clinics Sean Diver Urology Advanced Nurse Practitioner candidate Letterkenny University Hospital 01/02/2018 Lower Urinary Tract Symptoms LUTS - one of
More informationThe Urology One-Stop Clinic
The Urology One-Stop Clinic Exceptional healthcare, personally delivered The aim of this leaflet is to answer any questions you may have about the Urology One-Stop Clinic. What is the Urology One-Stop
More informationMUSCLE - INVASIVE AND METASTATIC BLADDER CANCER
10 MUSCLE - INVASIVE AND METASTATIC BLADDER CANCER Recommendations from the EAU Working Party on Muscle Invasive and Metastatic Bladder Cancer G. Jakse (chairman), F. Algaba, S. Fossa, A. Stenzl, C. Sternberg
More informationDiagnosis and testing in primary care for urological cancers
The Royal Marsden Diagnosis and testing in primary care for urological cancers Alan Thompson Consultant Urological Surgeon 2 The Royal Marsden GP Education Day 7 th July 2017 3 The Royal Marsden GP Education
More informationDiagnosis and Management of UTI s in Care Home Settings. To Dip or Not to Dip?
Diagnosis and Management of UTI s in Care Home Settings To Dip or Not to Dip? 1 Key Summary Points: Treat the patient NOT the urine In people 65 years, asymptomatic bacteriuria is common. Treating does
More informationProfessor Suetonia Palmer
Professor Suetonia Palmer Department of Medicine Nephrologist Christchurch Hospital Christchurch 14:00-14:55 WS #108: The Kidney Test - When To Test and When to Refer ( and When Not To) 15:05-16:00 WS
More informationUrological Tumours 1 Kidney tumours 2 Bladder tumours
Urological Tumours 1 Kidney tumours 2 Bladder tumours Tim Bracey SpR Histopathology Derriford Hospital Kidney tumours What are we going to talk about?! Anatomy of urinary tract! Types of kidney tumours!
More informationThe Royal Marsden. MDT case study. Mr Alan Thompson Consultant Urological Surgeon The Royal Marsden
MDT case study Mr Alan Thompson Consultant Urological Surgeon The Royal Marsden 2 The Royal Marsden Case history 56 year old lady from Bangladesh with 5 children Rarely seen her GP over the last 10 years
More informationCare of bladder cancer patients diagnosed in Northern Ireland 2010 & 2011 (Summary)
Care of bladder cancer patients diagnosed in 2010 & 2011 (Summary) Bannon, F., Ranaghan, L., & Gavin, A. (2014). Care of bladder cancer patients diagnosed in 2010 & 2011 (Summary). N. Cancer Registry,
More informationMale Lower Urinary Tract Symptoms: Management in primary care and beyond. Daniel Cohen PhD FRCS(Urol) Consultant Urological Surgeon
Male Lower Urinary Tract Symptoms: Management in primary care and beyond Daniel Cohen PhD FRCS(Urol) Consultant Urological Surgeon 1 LUTS Very common: 1/3 men over age of 50 have moderate to severe LUTS
More informationYou have been booked for a. Flexible Cystoscopy. Under Local Anaesthetic
You have been booked for a Flexible Cystoscopy Under Local Anaesthetic 1 WHAT IS A FLEXIBLE CYSTOSCOPY A flexible cystoscopy is a test to examine the uretha (waterpipe) and bladder using a thin, lighted
More informationThe Royal Marsden. Prostate case study. Presented by Mr Alan Thompson Consultant Urological Surgeon
Prostate case study Presented by Mr Alan Thompson Consultant Urological Surgeon 2 Part one Initial presentation A 62 year old male solicitor attends your GP surgery. He has rarely seen you over the last
More informationPrimary Care Approach to Management of CKD
Primary Care Approach to Management of CKD This PowerPoint was developed through a collaboration between the National Kidney Foundation and ASCP. Copyright 2018 National Kidney Foundation and ASCP Low
More informationBladder Cancer Knowing the Risks and Warning Signs. Part II: Warning Signs
Bladder Cancer Knowing the Risks and Warning Signs Part II: Warning Signs May 8, 2018 Presented by: is the Director of Urologic Oncology at MedStar Washington Hospital Center and an Assistant Professor
More informationClinical guideline Published: 22 August 2007 nice.org.uk/guidance/cg54
Urinary tract infection in under 16s: diagnosis and management Clinical guideline Published: 22 August 2007 nice.org.uk/guidance/cg54 NICE 2017. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-ofrights).
More informationMANAGING BENIGN PROSTATIC HYPERTROPHY IN PRIMARY CARE DR GEORGE G MATHEW CONSULTANT FAMILY PHYSICIAN FELLOW IN SEXUAL & REPRODUCTIVE HEALTH
MANAGING BENIGN PROSTATIC HYPERTROPHY IN PRIMARY CARE DR GEORGE G MATHEW CONSULTANT FAMILY PHYSICIAN FELLOW IN SEXUAL & REPRODUCTIVE HEALTH INTRODUCTION (1) Part of male sexual reproductive organ Size
More informationEMPIRICAL TREATMENT OF SELECT INFECTIONS ADULT GUIDELINES. Refer to VIHA Algorithm for the empiric treatment of Urinary Tract Infection
URINARY TRACT Refer to VIHA Algorithm for the empiric treatment of Urinary Tract Infection and Asymptomatic Bacteriuria on the VIHA Intranet: https://intranet.viha.ca/departments/pharmacy/clinical_pharmacy/pages/infec
More informationChronic kidney disease (CKD) (Southampton pathway)
Background information Patient information Key messages for this pathway Definitions and abbreviations used in this pathway Classification of CKD Diagnosis of CKD Summary of referral criteria Screening
More informationGuidelines for the management of urinary tract infections in children 0-17 years
Guidelines for the management of urinary tract infections in children 0-17 years Guideline to be used where appropriate in conjunction with the Ashford and St Peter s sepsis guideline (Dr Ruth Mew 2016)
More informationHaematuria Clinic. Information for patients Urology PROUD TO MAKE A DIFFERENCE SHEFFIELD TEACHING HOSPITALS NHS FOUNDATION TRUST
Haematuria Clinic Information for patients Urology PROUD TO MAKE A DIFFERENCE SHEFFIELD TEACHING HOSPITALS NHS FOUNDATION TRUST The Haematuria Clinic You have been referred to the Haematuria Clinic as
More informationThe primary care perspective Dr Richard Roope
The primary care perspective Dr Richard Roope RCGP & CRUK Clinical Lead for Cancer CRUK Senior Clinical Advisor (Prevention and Early Diagnosis) The challenges within primary care Cancer in the primary
More informationIdentification, management and referral of adults with chronic kidney disease: concise guidelines
Identification, management and referral of adults with chronic kidney disease: concise guidelines Abstract Chronic Kidney Disease (CKD) is often thought to be a relatively rare condition requiring specialist
More informationTumour Markers. For these reasons, only a handful of tumour markers are commonly used by most doctors.
Tumour Markers What are Tumour Markers? Tumour markers are substances that can be found in the body when cancer is present. They are usually found in the blood or urine. They can be products of cancer
More informationPatient Group Direction for the Supply of Nitrofurantoin MR 100mg capsules
October 2016 Patient Group Direction for the Supply of Nitrofurantoin MR 100mg capsules This Patient Group Direction (PGD) is a specific written instruction for the supply and/or administration of nitrofurantoin
More informationHMM 4401 Genito-urinary tract diseases
HMM 4401 Genito-urinary tract diseases Urine production Core elements: Glomerulus, proximal and distal convoluted tube, loop of Henle, collecting tubules, ureters, bladder, sphincter, uretra, and out
More informationFlexible Cystoscopy. Patient Information
Flexible Cystoscopy Patient Information 05/11/2012 Mehul Pankaj Raithatha 3 rd Year Medical Student Barts and the London - School of Medicine and Dentistry INTRODUCTION The urinary bladder is the organ
More informationChronic kidney disease screening and assessment
Care map information Information resources for patients and carers Aboriginal and Torres Strait Islanders DEFINITION OF CKD egfr
More informationADVICE TO PATIENTS REQUESTING PSA MEASUREMENT FREQUENTLY-ASKED QUESTIONS
The British Association of Urological Surgeons 35-43 Lincoln s Inn Fields London WC2A 3PE Phone: Fax: Website: E-mail: +44 (0)20 7869 6950 +44 (0)20 7404 5048 www.baus.org.uk admin@baus.org.uk ADVICE TO
More informationThe National Quality Standards for Chronic Kidney Disease
The National Quality Standards for Chronic Kidney Disease Dr Robert Lewis Chief of Service, Wessex Kidney Centre, Portsmouth Specialist Committee Member Quality Standard for Chronic Kidney Disease, NICE
More informationCystoscopy and urethroscopy
Page 1 of 5 Cystoscopy and urethroscopy Introduction This leaflet is provided to give you information about undergoing cystoscopy and/or urethroscopy. What is a cystoscopy? A cystoscopy is a procedure
More informationProstate surgery. What is the prostate? What is a TURP? Why is a TURP operation necessary? Deciding to have a TURP operation.
What is the prostate? The prostate is a gland about the size of a walnut that is only present in men. It is located just below the bladder and surrounds the urethra, the tube through which urine flows
More informationChronic Kidney Disease (CKD) and egfr: Decision and Dilemma. Dr Bhavna K Pandya Consultant Nephrologist University Hospital Aintree
Chronic Kidney Disease (CKD) and egfr: Decision and Dilemma Dr Bhavna K Pandya Consultant Nephrologist University Hospital Aintree Topics CKD background egfr background Patient with egfr Referral Guidelines
More informationMini-Invasive Treatment in Urological Diseases Dott. Alberto Saita Responsabile Endourologia Istituto Clinico Humanitas - Rozzano
Dipartimento di Urologia Direttore Prof. Giorgio Guazzoni Mini-Invasive Treatment in Urological Diseases Dott. Alberto Saita Responsabile Endourologia Istituto Clinico Humanitas - Rozzano alberto.saita@humanitas.it
More informationLRI Children s Hospital
LRI Children s Hospital Management of Henoch Schönlein Purpura (HSP) in children Staff relevant to: Clinical staff working within the UHL Children s Hospital. Team approval date: July 2017 Version: V 3
More informationASYMPTOMATIC MICROSCOPIC HEMATURIA IN WOMEN JOLYN HILL, MD ASSISTANT PROFESSOR, CLINICAL UROGYNECOLOGY FEBRUARY14, 2017
ASYMPTOMATIC MICROSCOPIC HEMATURIA IN WOMEN JOLYN HILL, MD ASSISTANT PROFESSOR, CLINICAL UROGYNECOLOGY FEBRUARY14, 2017 DISCLOSURES No financial disclosures Urogynecologist via Ob/Gyn pathway ASYMPTOMATIC
More informationGuidelines for the Management of Prostate Cancer West Midlands Expert Advisory Group for Urological Cancer
Guidelines for the Management of Prostate Cancer West Midlands Expert Advisory Group for Urological Cancer West Midlands Clinical Networks and Clinical Senate Coversheet for Network Expert Advisory Group
More informationMr Declan Cahill Consultant Urological Surgeon The Royal Marsden
Diagnosing prostate cancer Mr Declan Cahill Consultant Urological Surgeon 2 Marsden GP Education Day 22 February 2016 Should I have a PSA test? Can I have a PSA test? prostatecanceruk.org 4 83% raised
More informationBladder Cancer Early Detection, Diagnosis, and Staging
Bladder Cancer Early Detection, Diagnosis, and Staging Detection and Diagnosis Catching cancer early often allows for more treatment options. Some early cancers may have signs and symptoms that can be
More informationRare Urological Cancers Urological Cancers SSCRG
Rare Urological Cancers Urological Cancers SSCRG Public Health England South West Knowledge & Intelligence Team 1 Introduction Rare urological cancers are defined here as cancer of the penis, testes, ureter
More informationLCA Lung Clinical Forum. 21 st October 2014
LCA Lung Clinical Forum 21 st October 2014 Welcome Dr Liz Sawicka Chair - LCA Lung Pathway Group Succession planning Dr Kate Haire Consultant in Public Health Medicine, LCA Commissioning Intentions for
More informationTier 3: The effectiveness of urinary biomarker genotypes (Cxbladder Detect) in the investigation of haematuria in Primary Care
National Health Committee Tier 3: The effectiveness of urinary biomarker genotypes (Cxbladder Detect) in the investigation of haematuria in Primary Care National Health Committee (NHC) The National Health
More informationEfficient and Effective Use of Exfoliative Markers
Innovations in Urologic Oncology: Bladder Cancer Efficient and Effective Use of Exfoliative Markers Jared M Whitson, MD April 9 th, 2010, CA URINARY TUMOR MARKERS Future Directions Urinary Tumor Markers
More informationSwindon Diabetes Guidelines: Management of Chronic Kidney Disease Associated with Diabetes Mellitus
Swindon Diabetes Guidelines: Management of Chronic Kidney Disease Associated with Diabetes Mellitus 1 Contents Executive Summary... 3 How to Screen for Diabetic Nephropathy... 4 What to Measure... 4 Frequency
More informationCosting report: Bladder cancer
Putting NICE guidance into practice Costing report: Bladder cancer Implementing the NICE guideline on bladder cancer (NG2) Published: February 2015 Updated September 2015 to update the unit cost of transurethral
More informationGuidelines for the Management of Renal Cancer West Midlands Expert Advisory Group for Urological Cancer
Guidelines for the Management of Renal Cancer West Midlands Expert Advisory Group for Urological Cancer West Midlands Clinical Networks and Clinical Senate Coversheet for Network Expert Advisory Group
More informationLower Urinary Tract Symptoms K Kuruvilla Zachariah Associate Specialist
Lower Urinary Tract Symptoms K Kuruvilla Zachariah Associate Specialist Lower Urinary Tract Symptoms Storage Symptoms Frequency, urgency, incontinence, Nocturia Voiding Symptoms Hesitancy, poor flow, intermittency,
More informationPhysicians are required to be scrupulously honest in their dealings with the College.
CENSURE: IC1902 DR. AARON MATTIS MELLON On September 19, 2014, in accordance with Section 47(1)(c) of The Medical Act, the Investigation Committee censured Dr. Mellon as a record of its disapproval of
More informationPediatric Nephrology Consult and Referral Guidelines
Pediatric Nephrology Consult and Referral Guidelines Introduction We see children and teens from birth to 21 years. The most common reasons patients are referred to pediatric nephrology services include:
More informationAchieving earlier diagnosis of cancer in Lincolnshire. Dr Martin Latham GP Cancer Lead Lincolnshire West CCG February 2018
Achieving earlier diagnosis of cancer in Lincolnshire Dr Martin Latham GP Cancer Lead Lincolnshire West CCG February 2018 The state of Lincolnshire Cancer Care Lincolnshire: The worst part of the country
More informationAttachment #2 Overview of Follow-up
Attachment #2 Overview of Follow-up Provided below is a general overview of follow-up and this may vary based on specific patient or cancer characteristics. Of note, Labs and imaging can be performed closer
More informationADVICE TO PATIENTS REQUESTING PSA MEASUREMENT
Frequently-Asked Questions What is the aim of this leaflet? Prostate cancer is a serious condition. The PSA test, which can give an early indication of prostate cancer, is available to you if you want
More informationHey Doc, there s blood in my urine Evaluation of hematuria. Christian S. Kuhr, MD FACS May 4, 2018
Hey Doc, there s blood in my urine Evaluation of hematuria Christian S. Kuhr, MD FACS May 4, 2018 Objectives Understand the algorithm for hematuria evaluation Know the differential diagnosis for hematuria
More informationBladder tumour resection (TURBT): procedure-specific information
PATIENT INFORMATION Bladder tumour resection (TURBT): procedure-specific information What is the evidence base for this information? This leaflet includes advice from consensus panels, the British Association
More informationGlossary of Terms Primary Urethral Cancer
Patient Information English Glossary of Terms Primary Urethral Cancer Advanced cancer A tumour that grows into deeper layers of tissue, adjacent organs, or surrounding muscles. Anaesthesia (general, spinal,
More informationNICE support for commissioning for urinary tract infection in infants, children and young people under 16
NICE support for commissioning for urinary tract infection in infants, children and young people under 16 July 2013 1 Introduction Implementing the recommendations from NICE guidance and other NICEaccredited
More informationUWE Bristol. UTI in Children. Angie Green Visiting Lecturer March 2011
UWE Bristol UTI in Children Angie Green Visiting Lecturer March 2011 Approx 2% children will develop acute febrile UTI Up to 10% girls will develop any kind of UTI Progressive scarring in children with
More informationDr Anna Lawrence. Mr Simon Van Rij
Mr Simon Van Rij Urologist OneSixOne Urology Auckland Dr Anna Lawrence Urologist Auckland Surgical Centre Auckland 8:30-9:25 WS #94: Management of Common Urologic Problems in General Practice 9:35-10:30
More informationNice CKD Clinical Guidelines 2014 The challenges and benefits they may bring toprimary care
Nice CKD Clinical Guidelines 2014 The challenges and benefits they may bring toprimary care Paula D Souza Senior CKD Nurse Specialist Royal Devon and Exeter Healthcare Trust Introduction Background What
More informationUrology Case Study Workbook - Questions
Urology Case Study Workbook - Questions Developed in Partnership with the CME tutors for the CME Network Facilitated by an educational grant by GlaxoSmithKline Date of Preparation. September 5th 2011 IE/DUTT/0025/11
More informationGetting to Diagnosis. Debbie Victor Uro-Oncology CNS Royal Cornwall Hospitals Trust
Getting to Diagnosis Debbie Victor Uro-Oncology CNS Royal Cornwall Hospitals Trust GP Visit Symptoms Reduced urinary flow Difficulty starting/stopping Urgency Frequency Nocturia Because a friend/relative
More informationAppendix 4 Urology Care Pathways
Appendix 4 Urology Care Pathways Cancer Care Pathways outline the steps and stages in the patient journey from referral through to diagnostics, staging, treatment, follow up, rehabilitation and if applicable
More informationAttachment #2 Overview of Follow-up
Attachment #2 Overview of Follow-up Provided below is a general overview of follow-up and this may vary based on specific patient or cancer characteristics. Of note, Labs and imaging can be performed closer
More informationThey are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:
Assessment and investigation of urinary incontinence in women bring together everything NICE says on a topic in an interactive flowchart. are interactive and designed to be used online. They are updated
More informationAlgorithm for Haematuria
Procedure that produces the answer to a question or the solution to a problem in a finite number of steps. Algorithm for Haematuria Helen Forristal MSc (ANP) BSc (Hons) IAUN 2013 Haematuria presence
More informationQuestions and Answers About the Prostate-Specific Antigen (PSA) Test
CANCER FACTS N a t i o n a l C a n c e r I n s t i t u t e N a t i o n a l I n s t i t u t e s o f H e a l t h D e p a r t m e n t o f H e a l t h a n d H u m a n S e r v i c e s Questions and Answers
More informationCorporate Medical Policy
Corporate Medical Policy Urinary Tumor Markers for Bladder Cancer File Name: Origination: Last CAP Review: Next CAP Review: Last Review: urinary_tumor_markers_for_bladder_cancer 5/2011 11/2017 11/2018
More informationInformation for Patients
Information for Patients Congenital Malformation in the Urinary Tract: Ureteral Duplication, Ureterocele, and Ectopic Ureter English Table of contents Ureteral Duplication... 3 Symptoms and Diagnosis...
More informationGuidelines for the management of a child with haematuria
Guidelines for the management of a child with haematuria Children s Kidney Centre University Hospital of Wales Cardiff CF14 4XW DISCLAIMER: These guidelines were produced in good faith by the author(s)
More information